"Designing Growth Strategies is in our DNA"

U.S. Intrathecal Drugs for Post-Operative Pain Management Market Size, Share & Industry Analysis, By Drug Class (Morphine, Baclofen, Ziconotide, Bupivacaine, Hydromorphone, Clonidine, Fentanyl, Sufentanil, and Others), By End-user (Hospitals, Ambulatory Surgical Centers, Pain Clinics, and Others), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI110417

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Surgical Procedures Requiring Intrathecal Drugs for Post-Operative Pain Management – by Key Procedures, 2023
      1. Transurethral Resection of the Prostate (TURP)
      2. Hip Replacement
      3. Knee Replacement
      4. Spinal Surgery
      5. Aortic Valve Replacement
      6. Coronary artery bypass surgery
      7. All Transplants (Kidney, Liver, Pancreas, Heart, and Lung)
      8. Colectomy
      9. Coronary artery bypass surgery
      10. Metabolic and Bariatric Surgery
    2. Overview: Drugs Used for Intrathecal Administration in Post Operative Pain Management
      1. Regulatory Scenario
        1. Approved Drugs for Intrathecal Use in Post-Operative Pain
        2. Off label Use of Drugs through Intrathecal Administration in Post-Operative Pain
      2. Brief Profiles of Drug Candidates
        1. Recommended Dose: Drugs for Intrathecal Administration in Post-Operative Pain
        2. Maximum Dose Per Day: Post-Operative Pain
        3. Efficacy, Safety, and Response Time, Etc.
      3. Pipeline Analysis: by Key Candidates
      4. Average Price Per mg, By Drug Type (Manufacturer Prices)
      5. Reimbursement for Drugs Used for Intrathecal Administration in Post-Operative Pain Management
    3. Overview: Monitoring of Patients After the Administration of Intrathecal Drugs
    4. Overview: Intrathecal Drug Administration for Post-Operative Pain Management - by Drug Delivery Type
    5. Average Dose and Cost of Intrathecal Drugs per Procedure - by Drug Type
    6. Penetration of Intrathecal Drugs - by Type in Key Surgeries Requiring These Drugs
  5. U.S. Intrathecal Drugs for Post-Operative Pain Management Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Morphine
      2. Baclofen
      3. Ziconotide
      4. Bupivacaine
      5. Hydromorphone
      6. Clonidine
      7. Fentanyl
      8. Sufentanil
      9. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Pain Clinics
      4. Others
  6. Competitive Analysis
    1. Key Players Current Marketed Products
    2. Pipeline Analysis & Projected Approvals
    3. Company Profiles
      1. Piramal Pharma Limited (Piramal Group)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Baxter
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Hikma Pharmaceuticals PLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Amneal Pharmaceuticals LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Fresenius SE & Co. KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. TerSera Therapeutics LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Table 01: U.S. Intrathecal Drugs for Post-Operative Pain Management Market Revenue (USD Million) Forecast, By Drug Class, 2019–2032

Table 02: U.S. Intrathecal Drugs for Post-Operative Pain Management Market Revenue (USD Million) Forecast, By End-user, 2019–2032

Figure 01: U.S. Intrathecal Drugs for Post-Operative Pain Management Market Revenue Breakdown (USD Million, %) by End-user, 2023 & 2032

Figure 02: U.S. Intrathecal Drugs for Post-Operative Pain Management Market Value Share (%), By Drug Class, 2023 & 2032

Figure 03: U.S. Intrathecal Drugs for Post-Operative Pain Management Market Value Share (%), By end-user, 2023 & 2032

US Intrathecal Drugs for Post-Operative Pain Management Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 108
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase